295 related articles for article (PubMed ID: 37304649)
1. The role of YAP in the control of the metastatic potential of oral cancer.
Ahmad US; Saravanan K; Wan H
Oncol Res; 2021; 29(6):377-391. PubMed ID: 37304649
[TBL] [Abstract][Full Text] [Related]
2. Desmoglein-3 induces YAP phosphorylation and inactivation during collective migration of oral carcinoma cells.
Ahmad US; Parkinson EK; Wan H
Mol Oncol; 2022 Apr; 16(8):1625-1649. PubMed ID: 35000271
[TBL] [Abstract][Full Text] [Related]
3. YAP Inhibition by Verteporfin Causes Downregulation of Desmosomal Genes and Proteins Leading to the Disintegration of Intercellular Junctions.
Huang Y; Ahmad US; Rehman A; Uttagomol J; Wan H
Life (Basel); 2022 May; 12(6):. PubMed ID: 35743822
[TBL] [Abstract][Full Text] [Related]
4. YAP signaling induces PIEZO1 to promote oral squamous cell carcinoma cell proliferation.
Hasegawa K; Fujii S; Matsumoto S; Tajiri Y; Kikuchi A; Kiyoshima T
J Pathol; 2021 Jan; 253(1):80-93. PubMed ID: 32985688
[TBL] [Abstract][Full Text] [Related]
5. A YAP/TAZ-Regulated Molecular Signature Is Associated with Oral Squamous Cell Carcinoma.
Hiemer SE; Zhang L; Kartha VK; Packer TS; Almershed M; Noonan V; Kukuruzinska M; Bais MV; Monti S; Varelas X
Mol Cancer Res; 2015 Jun; 13(6):957-68. PubMed ID: 25794680
[TBL] [Abstract][Full Text] [Related]
6. Evidence for the Desmosomal Cadherin Desmoglein-3 in Regulating YAP and Phospho-YAP in Keratinocyte Responses to Mechanical Forces.
Uttagomol J; Ahmad US; Rehman A; Huang Y; Laly AC; Kang A; Soetaert J; Chance R; Teh MT; Connelly JT; Wan H
Int J Mol Sci; 2019 Dec; 20(24):. PubMed ID: 31835537
[TBL] [Abstract][Full Text] [Related]
7. Yes-associated protein promotes cell migration via activating Wiskott-Aldrich syndrome protein family member 1 in oral squamous cell carcinoma.
Qi L; Shi C; Li J; Xu S; Han Y; Li J; Zhang L
J Oral Pathol Med; 2019 Apr; 48(4):290-298. PubMed ID: 30697796
[TBL] [Abstract][Full Text] [Related]
8. The Regulation of the Hippo Pathway by Intercellular Junction Proteins.
Ahmad US; Uttagomol J; Wan H
Life (Basel); 2022 Nov; 12(11):. PubMed ID: 36362947
[TBL] [Abstract][Full Text] [Related]
9. Induction of apoptosis using ATN as a novel Yes-associated protein inhibitor in human oral squamous cell carcinoma cells.
Chu PC; Dokla EME; Hu JL; Weng JR
Environ Toxicol; 2022 Jun; 37(6):1404-1412. PubMed ID: 35212453
[TBL] [Abstract][Full Text] [Related]
10. GPR39 Overexpression in OSCC Promotes YAP-Sustained Malignant Progression.
Jiang Y; Li T; Wu Y; Xu H; Xie C; Dong Y; Zhong L; Wang Z; Zhao H; Zhou Y; Li J; Ji N; Zeng X; Feng X; Chen Q
J Dent Res; 2020 Jul; 99(8):949-958. PubMed ID: 32325008
[TBL] [Abstract][Full Text] [Related]
11. Hippo-YAP signaling activation and cross-talk with PI3K in oral cancer: A retrospective cohort study.
Rodrigo JP; Rodríguez-Santamarta T; Corte D; García-de-la-Fuente V; Rodríguez-Torres N; Lequerica-Fernández P; Lorz C; García-Pedrero JM; de Vicente JC
Oral Dis; 2024 Mar; 30(2):149-162. PubMed ID: 35951471
[TBL] [Abstract][Full Text] [Related]
12. LATS2 induced by TNF-alpha and inhibited cell proliferation and invasion by phosphorylating YAP in oral squamous cell carcinoma.
Dong C; Wei KJ; Zhang WB; Sun H; Pan HY; Zhang L
J Oral Pathol Med; 2015 Jul; 44(6):475-81. PubMed ID: 25782587
[TBL] [Abstract][Full Text] [Related]
13. The Hippo pathway transcriptional co-activator, YAP, confers resistance to cisplatin in human oral squamous cell carcinoma.
Yoshikawa K; Noguchi K; Nakano Y; Yamamura M; Takaoka K; Hashimoto-Tamaoki T; Kishimoto H
Int J Oncol; 2015; 46(6):2364-70. PubMed ID: 25846049
[TBL] [Abstract][Full Text] [Related]
14. Targeting the Hippo Signaling Pathway for Tissue Regeneration and Cancer Therapy.
Juan WC; Hong W
Genes (Basel); 2016 Aug; 7(9):. PubMed ID: 27589805
[TBL] [Abstract][Full Text] [Related]
15. Hippo Pathway and YAP Signaling Alterations in Squamous Cancer of the Head and Neck.
Santos-de-Frutos K; Segrelles C; Lorz C
J Clin Med; 2019 Dec; 8(12):. PubMed ID: 31817001
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemistry of YAP and dNp63 and survival analysis of patients bearing precancerous lesion and oral squamous cell carcinoma.
Ono S; Nakano K; Takabatake K; Kawai H; Nagatsuka H
Int J Med Sci; 2019; 16(5):766-773. PubMed ID: 31217745
[No Abstract] [Full Text] [Related]
17. Knockdown of lncRNA LEF1-AS1 inhibited the progression of oral squamous cell carcinoma (OSCC) via Hippo signaling pathway.
Zhang C; Bao C; Zhang X; Lin X; Pan D; Chen Y
Cancer Biol Ther; 2019; 20(9):1213-1222. PubMed ID: 30983488
[TBL] [Abstract][Full Text] [Related]
18. The crosstalk between AXL and YAP promotes tumor progression through STAT3 activation in head and neck squamous cell carcinoma.
Li J; Shi C; Zhou R; Han Y; Xu S; Ma H; Zhang Z
Cancer Sci; 2020 Sep; 111(9):3222-3235. PubMed ID: 32589311
[TBL] [Abstract][Full Text] [Related]
19. The transcriptional co-activator YAP: A new player in head and neck cancer.
Segrelles C; Paramio JM; Lorz C
Oral Oncol; 2018 Nov; 86():25-32. PubMed ID: 30409308
[TBL] [Abstract][Full Text] [Related]
20. Yes-associated protein expression in head and neck squamous cell carcinoma nodal metastasis.
Ge L; Smail M; Meng W; Shyr Y; Ye F; Fan KH; Li X; Zhou HM; Bhowmick NA
PLoS One; 2011; 6(11):e27529. PubMed ID: 22096589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
